Elsa U. Pardee Memorial Cancer Lecture
Understanding Your Inherited Cancer Risk
Goutham Narla, M.D., Ph.D.
Is the chief of the Division of Genetic Medicine at Michigan Medicine and is an associate professor in the Department of Internal Medicine. He was named the first Harrington Distinguished Scholar (Early Career Award) in 2012 and is currently the president of The Young Scientist Foundation. Dr. Narla earned his B.S. in Biology and Economics from Santa Clara University in California and his M.D. and Ph.D. from Mount Sinai School of Medicine in New York. He also completed his residency in Internal Medicine and fellowship in Medical Genetics at Mount Sinai.
Between five to 10 percent of cancers are thought to be hereditary. A hereditary cancer refers to a genetic change or mutation that may be passed through the family that causes a higher than normal risk of cancer. The most common hereditary cancers usually involve breast, ovarian, colon and endometrial (uterine) cancers, but almost any type of cancer can be hereditary.
Join Goutham Narla, M.D., Ph.D., chief of the Division of Genetic Medicine at Michigan Medicine, as he discusses the role that genetics play in a person's overall disease risk, the personal risk for disease based on family history, and when it's recommended to undergo genetic testing and see a genetic counselor.
Immediately following the key note speaker, a panel including MidMichigan Health Genetic Counselors Rebecca MacFalda, M.S., C.G.C., and Brittany Allen, M.G.C., C.G.C., will participate in an interactive question and answer session.
The Elsa U. Pardee Foundation has been instrumental in developing MidMichigan’s Oncology Services Program, as well as supporting this annual lecture.